Increased risk of major bleeding in underweight patients with atrial fibrillation who were prescribed non-vitamin K antagonist oral anticoagulants

CS Park, EK Choi, HM Kim, SR Lee, MJ Cha, S Oh - Heart Rhythm, 2017 - Elsevier
Background There is a paucity of evidence regarding the effects of non-vitamin K antagonist
oral anticoagulants (NOACs) in underweight patients with atrial fibrillation (AF). Objective …
被引用次数：71 相关文章

Increased risk of major bleeding in underweight patients with atrial fibrillation who were prescribed non-vitamin K antagonist oral anticoagulants

CS Park, EK Choi, HM Kim, SR Lee, MJ Cha… - Heart …, 2017 - snucm.elsevierpure.com
Background There is a paucity of evidence regarding the effects of non-vitamin K antagonist
oral anticoagulants (NOACs) in underweight patients with atrial fibrillation (AF). Objective …

Increased risk of major bleeding in underweight patients with atrial fibrillation who were prescribed non-vitamin K antagonist oral anticoagulants

CS Park, EK Choi, HM Kim, SR Lee… - HEART …, 2017 - scholarworks.bwise.kr
BACKGROUND There is a paucity of evidence regarding the effects of non-vitamin K
antagonist oral anticoagulants (NOACs) in underweight patients with atrial fibrillation (AF) …

Increased risk of major bleeding in underweight patients with atrial fibrillation who were prescribed non-vitamin K antagonist oral anticoagulants.

CS Park, EK Choi, HM Kim, SR Lee, MJ Cha, S Oh - Heart Rhythm, 2016 - europepmc.org
Background There is a paucity of evidence regarding the effects of non-vitamin K antagonist
oral anticoagulants (NOACs) in underweight patients with atrial fibrillation (AF). Objective …

Increased risk of major bleeding in underweight patients with atrial fibrillation who were prescribed non-vitamin K antagonist oral anticoagulants

CS Park, EK Choi, HM Kim, SR Lee, MJ Cha, S Oh - Heart Rhythm, 2017 - infona.pl
There is a paucity of evidence regarding the effects of non-vitamin K antagonist oral
anticoagulants (NOACs) in underweight patients with atrial fibrillation (AF). The purpose of …

Increased risk of major bleeding in underweight patients with atrial fibrillation who were prescribed non-vitamin K antagonist oral anticoagulants

CS Park, EK Choi, HM Kim, SR Lee, MJ Cha… - Heart …, 2017 - pubmed.ncbi.nlm.nih.gov
Background There is a paucity of evidence regarding the effects of non-vitamin K antagonist
oral anticoagulants (NOACs) in underweight patients with atrial fibrillation (AF). Objective …

Increased risk of major bleeding in underweight patients with atrial fibrillation who were prescribed non-vitamin K antagonist oral anticoagulants

CS Park, EK Choi, HM Kim, SR Lee, MJ Cha… - Heart …, 2017 - heartrhythmjournal.com
Background There is a paucity of evidence regarding the effects of non-vitamin K antagonist
oral anticoagulants (NOACs) in underweight patients with atrial fibrillation (AF). Objective …

[引用][C] Increased risk of major bleeding in underweight patients with atrial fibrillation who were prescribed non-vitamin K antagonist oral anticoagulants

CS Park, EK Choi, HM Kim, SR Lee, MJ Cha, S Oh - Heart Rhythm, 2017 - cir.nii.ac.jp
Increased risk of major bleeding in underweight patients with atrial fibrillation who were
prescribed non-vitamin K antagonist oral anticoagulants | CiNii Research CiNii 国立情報学 …